Eli Lilly Stock Jumps On Strong Earnings, Guidance As Zepbound Sales Easily BeatInvestors Business Daily • 04/30/24
Eli Lilly's stock jumps as first-quarter profit tops estimates amid strong sales of Mounjaro, ZepboundMarket Watch • 04/30/24
Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, MounjaroCNBC • 04/30/24
Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline MomentumPRNewsWire • 04/30/24
Gear Up for Lilly (LLY) Q1 Earnings: Wall Street Estimates for Key MetricsZacks Investment Research • 04/25/24
Which Companies Will Join the Trillion-Dollar Team in 2024? Our 3 Best GuessesInvestorPlace • 04/24/24
Should Eli Lilly (LLY) Be in Your Portfolio Ahead of Q1 Earnings?Zacks Investment Research • 04/24/24
Meet Eli Lilly's Secret Weapon in the Billion-Dollar Weight-Loss Drug MarketThe Motley Fool • 04/24/24
Hagens Berman Signals Major Turning Point in Insulin Fair Pricing Class-Action LawsuitBusiness Wire • 04/23/24